Bright Peak Therapeutics AG - top100startup.ch

Company

Bright Peak Therapeutics AG

Incorporated

December 2017

Headquarter

Basel

Biotech

Next-generation engineered cytokines

Bright Peak is developing next-generation engineered cytokines for immuno-oncology indications.

Company News

Find here the latest news about the company.

21.10.2024 Bright Peak Therapeutics enters the clinic with first immunotherapy for cancer (startupticker.ch)
21.10.2024 Bright Peak Therapeutics enters the clinic with first immunotherapy for cancer (startupticker.ch)
17.06.2024 Bright Peak Therapeutics raises USD90 million to advance lead program into clinical trials (startupticker.ch)
14.06.2024 Bright Peak Therapeutics secures USD 90 million in Series C funding to propel innovative immunotherapy forward (venturelab.swiss)
16.12.2022 The 18 most promising biotech startups, according to investors (TOP 100)
21.03.2022 Seasoned Board Members for Swiss Startups (startupticker.ch)
14.06.2021 Bright Peak Therapeutics Closes $107 Million Financing Round (startupticker.ch)
29.07.2020 Bright Peak off to a good start with $35 million from Versant Ventures (startupticker.ch)

Company Awards

TOP 100 Swiss Startups 2022